BPC-157 Lyme Disease Research Mechanism — Peptide Pathways No published clinical trial has tested BPC-157 in human Lyme disease patients. That's the first thing to establish. What exists instead is a growing body of pre…
Read articleBPC-157 for Lyme Disease Research — Clinical Evidence Research from the University of Zagreb found that BPC-157 (Body Protection Compound-157) demonstrated neuroprotective properties in animal models of neuroinflammatio…
Read articleDoes BPC-157 Help Lyme Disease Research? (Current Data) Nearly 476,000 Americans are diagnosed with Lyme disease annually according to CDC surveillance data published in 2021. Yet treatment protocols for chronic Lyme re…
Read articleBPC-157 Studied Lyme Disease Research — What We Know Researchers at multiple institutions have begun investigating BPC-157 (Body Protection Compound-157) as a potential adjunct therapy for Lyme disease complications. No…
Read articleThymosin Alpha-1 Chronic Infection Research Mechanism Chronic hepatitis B, tuberculosis, and invasive fungal infections share a clinical frustration: even with pathogen-specific antimicrobials, a subset of patients neve…
Read articleThymosin Alpha-1 for Chronic Infection Research A 2023 meta-analysis published in the Journal of Clinical Immunology covering 1,847 patients with chronic hepatitis B found that thymosin alpha-1 adjuvant therapy increase…
Read articleThymosin Alpha-1 Chronic Infection Research Evidence Peer-reviewed research from institutions including the Chinese University of Hong Kong and the University of Rome has documented thymosin alpha-1's ability to restore…
Read articleDoes Thymosin Alpha-1 Help Chronic Infection Research? A 2019 meta-analysis published in the Journal of Clinical Virology found that thymosin alpha-1 (Tα1) administration reduced viral load in chronic hepatitis B patien…
Read articleThymosin Alpha-1 EBV Research Mechanism — Immune Modulation Research published in the Journal of Interferon & Cytokine Research found that thymosin alpha-1 (Tα1) administration increased interferon-gamma production in p…
Read articleDoes Thymosin Alpha-1 Help EBV Research? (Clinical Evidence) Epstein-Barr virus doesn't disappear after acute infection. It hides inside B-cells, waiting for immune lapses to reactivate. For the 10–15% of patients who d…
Read articleThymosin Alpha-1 Studied EBV Research — Clinical Findings A 2024 double-blind trial published in Clinical Immunology found that thymosin alpha-1 reduced Epstein-Barr virus DNA copies by 68% in patients with chronic acti…
Read articleThymosin Alpha-1 Studied Autoimmune Research — Key Findings A 2019 systematic review published in Frontiers in Immunology analysed 47 clinical trials examining thymosin alpha-1's effects on immune dysregulation. The pep…
Read articleThymosin Alpha-1 Autoimmune Research Mechanism Explained Research published in the Journal of Immunology Research found that thymosin alpha-1 (Tα1) increases CD4+CD25+FoxP3+ T-regulatory cell populations by 40–60% in au…
Read articleThymosin Alpha-1 for Autoimmune Research — Immune Modulation A 2022 study published in Frontiers in Immunology found that thymosin alpha-1 (Tα1) administration increased CD4+CD25+Foxp3+ regulatory T-cell populations by …
Read articleThymosin Alpha-1 Studied Hashimoto's Research — Evidence A 2019 pilot study published in the journal Endocrine Connections found that thymosin alpha-1 (Tα1) reduced thyroid-stimulating hormone (TSH) levels by an average…
Read articleThymosin Alpha-1 Hashimoto's Research Mechanism Explained A 2023 pilot study published in the Journal of Clinical Endocrinology & Metabolism found that patients with Hashimoto's thyroiditis who received thymosin alpha-1…
Read articleDoes Thymosin Alpha-1 Help Hashimoto's Research? A 2019 study published in International Immunopharmacology found that thymosin alpha-1 (Tα1) reduced thyroid peroxidase antibody (TPO-Ab) levels by 32% in a murine model …
Read articleThymosin Alpha-1 for Hashimoto's Research Insights Research published in the International Journal of Immunopathology and Pharmacology found that six-month Thymosin Alpha-1 protocols reduced anti-TPO antibodies by 30–40…
Read articleThymosin Alpha-1 Studied Lupus Research — What We Know A 2019 pilot study published in Clinical Rheumatology found that thymosin alpha-1 reduced anti-dsDNA antibody titers. The primary biomarker for lupus disease activi…
Read articleThymosin Alpha-1 Lupus Research — Mechanism & Clinical Data Researchers at the Chinese PLA General Hospital published a 2022 randomised controlled trial showing that thymosin alpha-1 combined with standard immunosuppres…
Read article